News

Oblon Named PTAB Firm of the Year

Oblon has been recognized as "PTAB Firm of the Year" by Managing Intellectual Property magazine for its second annual PTAB litigation ranking. This award recognizes Oblon's outstanding work and reputation in representing petitioners and patent owners before the Patent Trial and Appeal Board at the United States Patent and Trademark Office. During Thursday night's award ceremony, the firm was also dubbed "Northeast Patent Prosecution Firm of the Year."

Managing Intellectual Property

Legal, Economic, and Political Challenges Facing the Global Pharmaceutical Industry in 2016

Richard Kelly was recently interviewed by Asia IP Law regarding the legal, economic and political challenges facing the global pharmaceutical industry in 2016. Mr. Kelly's contributions to the piece will be published in the March issue of the magazine.

Asia IP Law

Oblon Shortlisted to Receive Multiple Managing IP Awards for 2016

The firm has been shortlisted to receive the following MIP US awards. Patent Prosecution- National PTAB- National Specialty IP Firm- National Patent Prosecution- Regional (Northeast)

Managing IP Magazine

PTAB's Ax Of Stanford DNA Test Patent Backed By Fed. Circ.

The Federal Circuit on Monday affirmed a Patent Trial and Appeal Board decision that the asserted claims of a prenatal DNA test patent owned by Stanford University are invalid because they are obvious and anticipated.

IP Law360

Oblon Ranks Among Top Firms Handling AIA Reviews at the PTAB

Oblon was recently highlighted in an IP Law360 article as a top firm for handing AIA reviews at the PTAB. Oblon ranked fourth in terms of overall number of AIA review cases in 2015.

IP Law360

Oblon Announces Election of One New Partner, New Senior Attorneys

Alexandria, VA – Oblon, McClelland, Maier & Neustadt, LLP is pleased to announce the election of one new partner- Sameer Gokhale- effective January 1, 2016.

Oblon Ranked Among Top 100 IP Firms by Number of Partners

In survey results recently published by IP Law360, Oblon was ranked #35 in the list of the "Top 100 IP Firms" by number of partners

IP Law360

Fed. Circ. Faults PTAB's Order Upholding Verinata Patent

Oblon was mentioned in a recent Law360 article regarding a recent Federal Circuit decision to vacate a PTAB decision in an inter partes review which upheld all of the claims of Verinata Health Inc.'s patent on a method of detecting fetal abnormalities.

IP Law360

Oblon Named a "Best Law Firm" by U.S. News and World Report

Oblon was named one of the "Best Law Firms" in the United States in 2019 by U.S. News and World Report and Best Lawyers.

U.S. News and World Report and Best Lawyers.

Insider's Perspective: Recent and Future Developments at the USPTO

On Friday, October 30, 2015, former USPTO Commissioner of Patents, Margaret Focarino, presented to a group of Japanese patent practitioners on recent and future developments in the USPTO. Ms. Focarino joined the firm earlier this fall and this group was among the first to hear her insightful views on the direction of the USPTO and the future of patenting in the U.S.

Oblon LLP